Calcimimetics and CaSR signaling in CKD-MBD: bone-immune-vascular crosstalk and therapeutic potential.

Zheng CM, Hsu HC, Hou YC, Lu CL, Zheng JQ, Lu KC

Open source

DOI
10.3389/fimmu.2026.1912252
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1912252,
  title = {Calcimimetics and CaSR signaling in CKD-MBD: bone-immune-vascular crosstalk and therapeutic potential.},
  author = {Zheng CM and Hsu HC and Hou YC and Lu CL and Zheng JQ and Lu KC},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1912252},
  url = {https://doi.org/10.3389/fimmu.2026.1912252}
}

RIS

TY  - JOUR
TI  - Calcimimetics and CaSR signaling in CKD-MBD: bone-immune-vascular crosstalk and therapeutic potential.
AU  - Zheng CM
AU  - Hsu HC
AU  - Hou YC
AU  - Lu CL
AU  - Zheng JQ
AU  - Lu KC
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1912252
UR  - https://doi.org/10.3389/fimmu.2026.1912252
ER  - 

APA

CM, Z., HC, H., YC, H., CL, L., JQ, Z., & KC, L. (2026). Calcimimetics and CaSR signaling in CKD-MBD: bone-immune-vascular crosstalk and therapeutic potential.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1912252

Source records